根据协议条款,Emergent BioSolutions将为SAB Biotherapeutics提供涵盖从研发到生产的全流程服务。此次合作将充分发挥Emergent在生物制药领域的技术专长和制造能力。
两家公司此次达成的战略合作,标志着在生物制药外包服务领域的深度整合。通过这项端到端服务协议,SAB Biotherapeutics有望加速其创新疗法的开发进程。
根据协议条款,Emergent BioSolutions将为SAB Biotherapeutics提供涵盖从研发到生产的全流程服务。此次合作将充分发挥Emergent在生物制药领域的技术专长和制造能力。
两家公司此次达成的战略合作,标志着在生物制药外包服务领域的深度整合。通过这项端到端服务协议,SAB Biotherapeutics有望加速其创新疗法的开发进程。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.